Do coagulation abnormalities contribute to sepsis associated organ failure?*

This publication has 11 references indexed in Scilit:

• Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia*
  Critical Care Medicine, 2006
• Identification of High and Low Responders to Lipopolysaccharide in Normal Subjects: An Unbiased Approach to Identify Modulators of Innate Immunity
  The Journal of Immunology, 2005
• Activated Protein C Inhibits Local Coagulation after Intrapulmonary Delivery of Endotoxin in Humans
  American Journal of Respiratory and Critical Care Medicine, 2005
• Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis
  Blood, 2004
• Expression and function of the endothelial protein C receptor in human neutrophils
  Blood, 2003
• Sepsis and Disseminated Intravascular Coagulation
  Journal of Thrombosis and Thrombolysis, 2003
• Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe Sepsis
  JAMA, 2003
• Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway
  Science, 2002
• Tissue Factor Pathway Inhibitor Does Not Influence Inflammatory Pathways during Human Endotoxemia
  The Journal of Infectious Diseases, 2001
• Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.
  Journal of Clinical Investigation, 1993